It is well documented that Akt activation plays a crucial role in antiapoptotic actions of IGF-I in breast cancer cells and our initial experiments clearly demonstrated that 1, 25-D3 treatment attenuated the survival effect of IGF-I in parental cell line but not in resistant MCF-7/VDR cells. This evidence concerns the gene IGF1 and breast cancer.